Research & Development

Browse our research documents and publications, view our product pipeline and learn more about our research partners.

Reports, publications, and papers

Browse relevant documents to see the insights and thought leadership that we’ve spear headed over the years.

Browse 9 Articles
Filter by:
Digital therapies

Clinician-Patient Communication: Time for a Wake-up Call?

In light of the launch of My Arthritis, Ampersand Health hosted an industry roundtable to discuss the future of clinician-patient communication.

Digital therapies

My Arthritis App: Q&A for Clinicians

We answer common questions that clinicians may have around the application and benefits of our My Arthritis app.

Digital therapies

Ampersand Health launches Whitepaper: Designing Digital Behaviour Change Interventions

The paper uncovers the evidence behind our digital therapeutics approach to managing immune-mediated inflammatory conditions (IMIDs) such as Inflammatory Bowel...

Digital therapies

The Approach to Effectiveness Evaluation and User-Centred Design

Comments from leading digital health apps at HETT 2019. In January 2019, the NHS Long Term Plan was released and Chapter 4 read ‘Digitally-enabled care will...

Digital therapies

NRAS and Ampersand Health Partner to Launch Innovative App to Help People with Rheumatoid Arthritis

My Arthritis empowers patients with timely, relevant information and is designed to improve quality of life and outcomes.

Digital therapies

Digital therapeutics: A step change for health and wellbeing

We have recently been featured in an article on PWC's tackling the importance of patient-centric digital health interventions.

Digital therapies

NHS Long Term Plan: Who Will Carry The Voice Of The Patient?

With the 70th anniversary of the NHS just passing and the new long term plan that has just been launched, we now have a good view of how the NHS will look like...

Digital therapies

Improving Patient Outcomes Through Mobile Health

Interest in mobile health from patients, healthcare providers and carers has never been greater. However, mHealth is still in an incredibly nascent stage and...

A New Model Of Care

Genuine digital therapeutics are challenging misconceptions around digital health and improving quality of life for patients with long term inflammatory...

Our HealthSuite can help manage a range of inflammatory conditions

Our research and development focuses on the full breadth of inflammatory and immuno-mediated conditions, enabling us to build an exciting roadmap of digital medicines.

Indications/Conditions
Discovery
Proof of Concept
In Trial
In Market
My IBD Care Inflammatory Bowel Disease
Discovery
Proof of Concept
In Trial
In Market
My Arthritis Inflammatory Arthritis
Discovery
Proof of Concept
In Trial
In Market
NETs Neuroendocrine Tumours
Discovery
Proof of Concept
In Trial
In Market
My Blood Sickle Cell Disease
Discovery
Proof of Concept
In Trial
In Market
My Derma Inflammatory Dermatitis
Discovery
Proof of Concept
In Trial
In Market
My MS Multiple Sclerosis
Discovery
Proof of Concept
In Trial
In Market

Neuroendocrine Tumours

Currently, an observational trial is underway that is looking into the effectiveness of using a mobile application to collect Patient Reported Outcome data of those receiving treatment for Neuroendocrine Tumours.

This study is being conducted by King's College Hospital, along with a national charity and a major pharmaceutical company. Individuals who live with Neuroendocrine Tumours live a lower quality of life due to their condition. We are exploring the role digital therapeutics could play to alleviate treatment burden and improve clinical coordination to help patients gain a better quality of life.

Sickle Cell Disease

A leading NHS Trust and The Health Foundation are researching how our My Blood app can improve the process of collecting information from patients to avoid unnecessary trips to the hospital.

The My Blood app helps patients recieve remote care and could alleviate treatment burden, leading to benefits for both clinicians and patients.

Partner hospitals

Our app content is co-created with leading experts from 2 London hospitals.

NHS - Barts Health & King's College Hospital

We are partnered with the NHS, the world’s largest public health provider.

Our partnership with the NHS has allowed us to perform significant research and gain invaluable insights into the conditions that we focus on.

National Charities

We have partnered with national charities including Crohn’s and Colitis UK and the National Rheumatoid Arthritis Society (NRAS).

Our partnerships with national charities allow us to gain important insights into the experiences of the communities we work with.

Cookies Policy

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Read about how we use cookies and how you can control them by clicking "Privacy Preferences". If you continue to use this site, you consent to our use of cookies.

Read more